Michael Clark Selected Research

Michael Clark Research Topics

Disease

3	Neoplasms (Cancer) 07/2021 - 01/2019
3	Pressure Ulcer (Bedsore) 06/2018 - 08/2010
3	Infections 01/2017 - 06/2006
3	Pain (Aches) 01/2009 - 01/2003
2	Stroke (Strokes) 04/2020 - 09/2008
2	Heart Diseases (Heart Disease) 01/2017 - 01/2014
2	Major Depressive Disorder (Major Depressive Disorders) 03/2012 - 12/2009
1	Ischemic Stroke 04/2022
1	COVID-19 08/2021
1	Mental Disorders (Mental Disorder) 02/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2020
1	Premature Birth (Birth, Premature) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Carcinoid Tumor (Carcinoid) 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019
1	Axial Spondyloarthritis 01/2019
1	Brain Injuries (Brain Injury) 11/2018
1	Meningitis 01/2017
1	Noncommunicable Diseases 11/2014
1	Lead Poisoning (Poisoning, Lead) 10/2014
1	Poisoning 10/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2012
1	Melanoma (Melanoma, Malignant) 04/2011
1	Wounds and Injuries (Trauma) 09/2010
1	Hematoma 09/2010
1	Anisocoria 09/2010
1	Substance-Related Disorders (Drug Abuse) 03/2010
1	Meningeal Tuberculosis (Tuberculous Meningitis) 03/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2008
1	Dementia (Dementias) 09/2008
1	Personality Disorders (Personality Disorder) 01/2008
1	Cognitive Dysfunction 01/2008
1	Opioid-Related Disorders (Opiate Addiction) 01/2008
1	Antisocial Personality Disorder (Antisocial Personality) 01/2008
1	Alzheimer Disease (Alzheimer's Disease) 01/2008
1	Tuberculosis (Tuberculoses) 06/2006
1	Fatigue 01/2006

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2020
3	Opioid Analgesics (Opioids)IBA 03/2010 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2011
2	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 01/2014
2	Monoamine Oxidase (MAO)IBA 03/2012 - 12/2009
2	Methadone (Dolophine)FDA LinkGeneric 03/2010 - 01/2008
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2022
1	VaccinesIBA 08/2021
1	ParaffinIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	gallium Ga 68 dotatateIBA 01/2019
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2019
1	Ustekinumab (CNTO 1275)FDA Link 01/2019
1	somatostatin receptor 2IBA 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	IronIBA 11/2018
1	SiliconesIBA 08/2015
1	Greenhouse GasesIBA 11/2014
1	IsotopesIBA 10/2014
1	Harmine (Telepathine)IBA 03/2012
1	Aldehyde DehydrogenaseIBA 04/2011
1	ElementsIBA 08/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2009
1	Drinking WaterIBA 11/2008
1	ProteomeIBA 11/2008
1	ArsenicIBA 11/2008
1	Indicators and Reagents (Reagents)IBA 09/2008
1	Pharmaceutical PreparationsIBA 01/2008
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2008
1	Donepezil (Aricept)FDA LinkGeneric 01/2008
1	Isoniazid (Ftivazide)FDA LinkGeneric 06/2006

Therapy/Procedure

3	Therapeutics 03/2012 - 01/2008
2	Drug Therapy (Chemotherapy) 03/2009 - 01/2009
1	Continuity of Patient Care 02/2021
1	Thrombectomy 04/2020
1	Nutritional Support (Artificial Feeding) 06/2018
1	Reoperation 01/2017
1	Middle Ear Ventilation (Tympanostomy) 01/2017
1	Trephining 09/2010
1	Occupational Therapy (Therapy, Occupational) 09/2008
1	Music Therapy 01/2006